,0
0,Is Catalent (CTLT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
1,Weight-loss drugs fuel boom for firms that fill syringes
2,FOCUS-Weight-loss drugs fuel boom for firms that fill syringes
3,Revvity's (RVTY) New Launch to Widen Access to Editing Technology
4,Catalent (CTLT) Down 6.5% Since Last Earnings Report: Can It Rebound?
5,3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio
6,Is Catalent Inc (CTLT) Set to Underperform? Analyzing the Factors Limiting Growth
7,UPDATE 2-Moderna to cut mRNA drug substance production at Lonza facility
8,Catalent Appoints David McErlane as Biologics Segment Leader
9,Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
